A smiling woman with dark, chin-length hair and a red top is featured in an image highlighting the availability of an effective Shingles vaccine in Ireland. The vaccine, which offers protection against the painful rash caused by the varicella-zoster virus, is available but comes with a significant price tag. The cost is at least €450, which has led to limited uptake among the population. Public health officials note that while the vaccine is effective, its high cost remains a barrier for many. The image serves as a visual reminder of the vaccine’s availability, contrasting with the financial challenge many face in accessing it. Despite the expense, the vaccine is recommended for individuals over the age of 50, as the risk of Shingles increases with age. The situation underscores the ongoing challenge of balancing medical necessity with affordability in healthcare.